Seòmar agus comataidhean

The Scottish Stroke Improvement Programme (SSIP) Lead conducts a review process and meets with all NHS boards to understand the provision of stroke services and create a local action plan to improve performance where needed.

We recognise that the Scottish Stroke Care Standards are challenging for the service and expect Stroke Managed Clinical Networks and Health Boards to work together to drive forward quality improvement programmes of work to achieve these.

The Office for National Statistics confirmed Scottish Canals as a Non-Departmental Public Body (NDPB) effective from April 2020. Scottish Canals has a responsibility to ensure that it conducts its core business of maintaining and improving Scotland’s canal network and is resourced by the Scottish Government to do so. Since 2019, the Organisation’s capital Grant in Aid allocation has increased by 87% and this is enabling the Organisation to plan, progress and successfully complete projects of large scale as an NDPB.

Scottish Canals also retains the ability to operate commercially when appropriate and work is currently being undertaken by the Organisation to analyse the success of its investment activities in recent years. This analysis will be shared with the Scottish Government in due course alongside recommendations to Ministers on how the Organisation takes forward its investment activities as an NDPB.

The retail handling fee is intended to ensure that the obligation to operate a return point is cost neutral for retailers. It is for Circularity Scotland Ltd (CSL) to manage this in a way that meets the needs of obligated businesses across Scotland.

Throughout the pandemic, a UK-wide approach to the procurement of therapeutics has been vital to allow the UK to have the buying power to secure significant numbers of therapeutics in a competitive global market. This approach has ensured patients across the UK have had equal access to safe and effective medicines.

Evusheld ® was developed and tested before the emergence of the Omicron variant, and the UK Medicines and Healthcare products Regulatory Agency’s (MHRA) conditional marketing authorisation outlined some remaining questions, including how effective Evusheld ® is against Omicron and the duration of its effect against current circulating variants. As a result, there is currently no established supply arrangement for Evusheld ® in the UK. The UK Health Security Agency (UKHSA) is carrying out further testing on the effectiveness of Evusheld ® against the Omicron variants which involve “live virus” tests taking place in the lab (“in vitro”). These tests are important because they provide certainty of the effectiveness of Evusheld ® against circulating variants and avoid the risk of introducing new variants through viral mutations.

The Scottish Government continues to closely monitor the outcome of further research to ensure that any decisions to make Evusheld ® available to patients in Scotland in the future are based on the best available evidence.

Scottish Government is committed to ensuring that everyone with liver disease is able to access the best possible care and support and benefit from healthcare services that are safe, effective and person-centred.

Although the Scottish Government has not directly undertaken any analysis into the impact of geographical variation in primary care pathways for the early detection of liver disease, we are aware of the work currently being conducted by one of our partners, British Liver Trust, who are gathering evidence on how best to improve the management of chronic liver disease in primary care.

Like all Non-Departmental Public Bodies, Scottish Canals are required to seek approval from the Scottish Government for funding proposals above agreed threshholds. This ensures that larger projects are both affordable and in the best interests of wider public funds spend.

Proposals relating to Stockingfield Bridge will be subject to this process and will require Scottish Government approval before any undertaking can be made. I have yet to receive such a proposal from Scottish Canals but will of course give any such proposal full consideration.

We are committed to become a world leading, innovation nation, which will help us grow our economy and create sustainable, green jobs. As the recent figures from the UK Innovation Survey show, there is still work to be done.

That is why this year we will publish new innovation strategy which will ensure that our businesses, people and institutions are ready to meet the global economic challenges and opportunities we face over the next 10 years.

The Strategy will build on the support already available to businesses through our Enterprise Agencies, who since 2017 have distributed around £600m directly to businesses to build their capacity and capability to innovate, and initiatives such as the Digital Development Grant, which since September 2020 has invested almost £50m to over 5,600 SMEs to help them utilise digital technologies and enhance workforce skills.

Since 2007 Scotland’s business R&D expenditure has doubled, whereas the comparable figure for the UK as a whole was only 29% growth over the same period.

We recently commissioned The Scottish Council for Development and Industry to undertake research on the specific barriers to innovation faced by Scottish businesses. The findings from the report, together with our engagement with industry and key stakeholders, will inform a reformed package of support within the Strategy to ensure our businesses realise their innovative potential.

The following table provides a breakdown of the core activity undertaken at the National Eye Centre at NHS Golden Jubilee, by month, since it opened in November 2020 up to the end of June 2022.

This does not include activity undertaken in main theatres at the NHS Golden Jubilee University National Hospital in 2020-21 prior to the National Eye Centre opening, nor any activity carried out in the National Eye Centre as part of the current independent sector contracts.

At June 2022 our latest published statistics show that Social Security Scotland had reached 3,061 employees with 1,050 these colleagues employed with Dundee as their office location.

By Autumn 2022 we expect Social Security Scotland to directly employ more than 3,500 people. We have made 2,000 offers of employment with new staff joining up until the end of 2022. We have 11 organised campaigns to launch with a Dundee specific location in 2022-23. We have/have not yet planned the specific Dundee campaigns for 2023-24.

The Scottish Government considers renewable, nuclear, bioenergy and energy from waste generation technologies to be low carbon. This is consistent with the definition used by the UK Government (BEIS).Most generation technologies are classified as low carbon by their type, and there is no carbon threshold used to determine this classification. Lifecycle emissions are used to classify bioenergy as low carbon, because whilst bioenergy is not necessarily low emissions at the point of generation, it is low carbon over its lifecycle.

Although nuclear power is designated as low carbon we do not support the building of new nuclear fission plants in Scotland under current technologies. Nuclear has high costs and provides poor value for money. It brings serious waste and environmental risks, and has long lead in times.